Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eargo is a medical device company dedicated to improving the quality of life for people with hearing loss through innovative, virtually invisible hearing aids. The company's flagship products are designed to be discreet, rechargeable, and comfortable, fitting entirely inside the ear canal to leverage the ear's natural anatomy for sound collection. Eargo operates primarily through a direct-to-consumer model and retail partnerships, providing professional hearing support and personalized devices without the traditional barriers of high costs and clinical visits. In 2023, the company transitioned from a public entity to a private one following its acquisition by Patient Square Capital.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ear.